Antisense modulation of B7 protein expression
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 3, 2006
Grant Date -
N/A
app pub date -
May 25, 2000
filing date -
Dec 31, 1996
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Compositions and methods for the diagnosis, prevention and treatment of immune states and disorders amenable to treatment through modulation of T cell activation are provided. In accordance with preferred embodiments, oligonucleotides are provided which are specifically hybridizable with nucleic acids encoding B7 proteins.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully